Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Dual-guide CRISPR Cas9-knockout screening for gene‑gene interaction analysis and beyond.
crispr app note
Application Note

Dual-guide CRISPR Cas9-knockout screening for gene‑gene interaction analysis and beyond.

This application note describes an optimized dual-guide CRISPR knockout screening platform, its applications, and the advantages it offers over conventional single-guide screening methods.

It also demonstrates Revvity's preclinical services capabilities to perform dual CRISPRko screens to examine gene interactions and synthetic lethality. Our team can manage the whole process, from custom library design to sophisticated data analysis, so that you can focus on the biological insights rather than the technical challenges of implementing dual guide screens.

Download Resource

Dual-guide CRISPR Cas9-knockout screening for gene‑gene interaction analysis and beyond.

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.